1CARON F,TREMBLAY S. Epidemiology of Acquisitionand Clearance of Cervical Human PapillomavirusInfection in Women from a High -Risk Area forCervical Cancer[J].Journal of Infectious Diseases, 1999,1 8 0 ( 5 ):1415. 被引量：1
3BOSCH F X , LORINCZ A , MUNOZ N , et al. Thecausal relation between human papillomavirus andcervical cancer[J]. Journal of Clinical Pathology, 2002,55(4):244. 被引量：1
4WALBOOMERS J M M,JACOBS M V , MANOS M M,etal. Human papillomavirus is a necessary cause of invasivecervical cancer worldwide[J].Journal of Pathology, 1999 ,189(1):12. 被引量：1
5Mutoz N ,Castellsague X ,Gonzalez A B D,et al. Chapter1 : HPV in the etiology of human cancer[J].Vaccine,2 0 0 6 , 2 4 ( 3 ):S3/1. 被引量：1
6CROW J M. HPV:The global burden[J].Nature,2012,4 8 8 ( 7 4 1 3 ):S2. 被引量：1
7Garland S M , Kjaer S K , Mufioz N , et al. Impact andEffectiveness of the Quadrivalent Human PapillomavirusVaccine: A Systematic Review of 10 Years of Real-worldExperience.[J]Clin Infect Dis. 2016,63(4):519. 被引量：1
8RYSER M D , MYERS E R , DURRETT R. HPV Clearanceand the Neglected Role of Stochasticity[J].Plos ComputationalBiology,2015,11(3) :e1004113. 被引量：1
4Nakagawa M,Stites DP, Palefsky JM, et al. CDC-positive and CD8-positive cytotoxic T lymphocytes contribute to human papilomavirus type 16 E6 and E7 responses[J]. Clin Diagn Lab Immunol, 1999,6:494-498. 被引量：1
5Youde SJ, Dunbar PR, Evans EM,et al. Use of fluorogenic histocompatibility leukocyte anfigen-A * 0201/HPV 16 E7 pepdde complexes to isolate rare human cytotoxic T-lymphocyte-recognizting endogenous human papillomavims antigens[J]. Cancer Res,2000,60:365-371. 被引量：1
6Hagensee ME,Koutsky LA,Lee SK, et al. Detection of cervical antibodies to human papillomavims type 16 ( HPV- 16 )antigens in relation to detection of HPV-16 DNA and cervical lesions[J] .J Infect Dis,2000,181 : 1234-1239. 被引量：1
7Kawana K, Yasugi T, Kanda T, et al. Neutralizing antibodies against oncogenic human papillomavirus as a possible determinant of the fate of low-grade cervical intraepithelial neoplasia[J]. Biochem Biophys Res Commun,2002,296:1{)2-105. 被引量：1
8Fausch SC, Silva DM,Rudolf MP,et al. Human papillomavirus vires-like pericles do not activate langerhans cells:a possible immune escape mechanism used by human papillomaviruses[J] .J Immunol,2002,169:3242-3249. 被引量：1
9Giannini SL, Hubert P, Doyen J, et al. Influence of the mucosal epithelium microenvironment on langerhans cells: impllcation for the devdopmenm of squamous intraepithelial lesions of the cervix[J] .Int J Cancer,2002,97:654-659. 被引量：1
10Georgopoulos NT, Proffitt JL, Blair GE. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins[J].Oncogene,2000,19:4930-4935. 被引量：1
